283 related articles for article (PubMed ID: 37432624)
1. Advances in Central Nervous System Tumor Classification.
Malta TM; Snyder J; Noushmehr H; Castro AV
Adv Exp Med Biol; 2023; 1416():121-135. PubMed ID: 37432624
[TBL] [Abstract][Full Text] [Related]
2. Classification of meningiomas-advances and controversies.
Harter PN; Braun Y; Plate KH
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S2. PubMed ID: 28595423
[TBL] [Abstract][Full Text] [Related]
3. [Classification and Molecular Diagnosis of Benign Brain Tumors].
Yoshimoto K
No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
[TBL] [Abstract][Full Text] [Related]
4. WHO grade and pathological markers of meningiomas: Clinical and prognostic role.
Franca RA; Della Monica R; Corvino S; Chiariotti L; Del Basso De Caro M
Pathol Res Pract; 2023 Mar; 243():154340. PubMed ID: 36738518
[TBL] [Abstract][Full Text] [Related]
5. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
7. Histological classification and molecular genetics of meningiomas.
Riemenschneider MJ; Perry A; Reifenberger G
Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
[TBL] [Abstract][Full Text] [Related]
8. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.
Cordova C; Kurz SC
Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
10. Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms.
Proctor DT; Ramachandran S; Lama S; Sutherland GR
World Neurosurg; 2018 Nov; 119():366-373. PubMed ID: 30138732
[TBL] [Abstract][Full Text] [Related]
11. Classification of human meningiomas: lights, shadows, and future perspectives.
Barresi V; Caffo M; Tuccari G
J Neurosci Res; 2016 Dec; 94(12):1604-1612. PubMed ID: 27376782
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification and grading of meningioma.
Nasrallah MP; Aldape KD
J Neurooncol; 2023 Jan; 161(2):373-381. PubMed ID: 36802047
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations in meningiomas: Literature review.
Pereira BJA; Oba-Shinjo SM; de Almeida AN; Marie SKN
Clin Neurol Neurosurg; 2019 Jan; 176():89-96. PubMed ID: 30553171
[TBL] [Abstract][Full Text] [Related]
14. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
16. TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Sahm F; Schrimpf D; Olar A; Koelsche C; Reuss D; Bissel J; Kratz A; Capper D; Schefzyk S; Hielscher T; Wang Q; Sulman EP; Adeberg S; Koch A; Okuducu AF; Brehmer S; Schittenhelm J; Becker A; Brokinkel B; Schmidt M; Ull T; Gousias K; Kessler AF; Lamszus K; Debus J; Mawrin C; Kim YJ; Simon M; Ketter R; Paulus W; Aldape KD; Herold-Mende C; von Deimling A
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26668184
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
18. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Goutagny S; Nault JC; Mallet M; Henin D; Rossi JZ; Kalamarides M
Brain Pathol; 2014 Mar; 24(2):184-9. PubMed ID: 24261697
[TBL] [Abstract][Full Text] [Related]
19. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
Front Oncol; 2022; 12():846232. PubMed ID: 35299730
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
